Nuclear Medicine Billing Experts

Nuclear Medicine Medical Billing Services

Nuclear medicine billing requires specialized knowledge of radiopharmaceutical codes and imaging procedure documentation.

Nuclear Medicine Medical Billing Services
95%

First-Pass Clean Claim Rate

$2.8K

Avg. Study Revenue Protected

4.0%

Client Denial Rate

20 Days

Average Days to Payment

Overview

Complete Revenue Capture for Nuclear Medicine Studies

Nuclear medicine billing requires specialized knowledge of radiopharmaceutical codes and imaging procedure documentation. Each nuclear medicine study has two billable components: the radiopharmaceutical supply (A9500-A9699) and the imaging procedure itself (78012-78999). Both must be billed together, and the specific radiopharmaceutical used must match the imaging study performed. Mismatches between supply and procedure codes trigger automatic denials.

PET scan billing (78811-78816) is particularly complex, with different codes for limited versus whole-body studies and different coverage criteria depending on the diagnosis. Medicare's National Coverage Determination for PET scans specifies which oncologic, cardiac, and neurologic indications are covered, and billing outside these parameters results in non-covered charges.

Complete Revenue Capture for Nuclear Medicine Studies
Challenges

Common Nuclear Medicine billing Challenges We Solve

Every Nuclear Medicine billing team deals with payer delays, coding nuance, and collection leakage. We tighten those weak points before they turn into write-offs.

Radiopharmaceutical Supply Coding

Every nuclear medicine procedure requires a paired radiopharmaceutical supply code (A9500-A9700). Selecting the correct HCPCS code based on the specific isotope, dose, and diagnostic versus therapeutic use is essential for reimbursement.

PET/CT Coverage and Authorization

PET/CT studies face varying coverage policies across payers and indications. Some oncology indications have broad coverage while others require prior authorization or are considered investigational. Staying current with coverage decisions prevents denials.

Component Billing for Imaging Studies

Nuclear medicine studies have professional (interpretation) and technical (equipment, isotope, technologist) components. Incorrect component billing or failure to split components when required leads to claim rejections and revenue leakage.

Therapeutic Nuclear Medicine Documentation

Therapeutic radiopharmaceutical treatments (I-131, Ra-223, Lu-177) require detailed documentation of dosimetry calculations, treatment justification, and radiation safety protocols. Inadequate documentation triggers medical necessity denials on high-cost treatments.

Services

Complete Nuclear Medicine billing Services

Support spans the full revenue cycle, from front-end verification to denial recovery and reporting.

Diagnostic nuclear medicine coding (78000-78999) with paired radiopharmaceutical supply codes

PET/CT oncology and cardiac billing (78811-78816, 78429-78434) with coverage verification

Therapeutic radiopharmaceutical billing (79005, 79101, 79403) with dosimetry documentation

Component billing management for professional and technical splits

Radiopharmaceutical HCPCS coding (A9500-A9700) with dose-specific accuracy

Prior authorization and appeals for PET/CT and therapeutic nuclear medicine studies

Coverage

Serving Nuclear Medicine billing Teams Nationwide

We support independent practices, multisite groups, and growing provider organizations with flexible workflows.

Independent physician groups

Multi-location practices

Private equity backed platforms

Hospital-owned outpatient groups

Guide

The Complete Guide to Nuclear Medicine billing

Nuclear Medicine Medical Billing Overview

Nuclear medicine is one of the most technically complex areas in all of diagnostic imaging billing, and the practices and hospital outpatient departments that bill it well are the ones that understand exactly what makes it different. When your team submits a claim for a myocardial perfusion imaging study or a PET scan, that claim must correctly reflect the radiopharmaceutical used, the number of imaging phases, the interpreting physician’s professional component, and the technical component, each in the correct billing context. Missing any one of those elements means incomplete reimbursement.

Your patients come to you at some of the most important moments in their medical care. A PET scan for cancer staging, a bone scan for metastatic disease evaluation, a cardiac stress test with perfusion imaging: these are studies that change treatment decisions. Making sure your practice gets fully compensated for that work so you can continue providing it is not just a financial concern. It is a patient care concern too.

Common Billing Challenges in Nuclear Medicine

  • Radiopharmaceutical billing complexity: HCPCS codes for radiopharmaceuticals (A9500-A9699 series) must be billed separately from the imaging procedure codes in most billing contexts. The specific agent used (Technetium Tc-99m sestamibi, Thallium Tl-201, FDG F-18) determines the correct HCPCS code. Submitting the wrong agent code, or omitting the radiopharmaceutical charge entirely, represents significant revenue loss per study.
  • Professional and technical component separation: Nuclear medicine imaging studies bill with Modifier 26 for the professional component (physician interpretation) and Modifier TC for the technical component (equipment, staff, radiopharmaceutical), or as a global service without modifiers in settings where the physician owns both components. Billing the wrong modifier combination for your practice’s specific arrangement with the facility creates systematic overpayment or underpayment issues.
  • PET scan coverage and prior authorization: Medicare covers PET imaging for specific oncologic and neurological indications, but coverage rules are procedure- and diagnosis-specific. Payers including Aetna and UnitedHealthcare maintain their own coverage determination policies for PET that do not always mirror Medicare. Submitting PET claims without prior authorization confirmation from commercial payers is the leading cause of high-dollar nuclear medicine denials.
  • Stress testing component billing: Cardiac stress tests paired with nuclear perfusion imaging involve two billable components: the stress test itself (CPT 93015 or 93016/93017/93018 when split by physician and technical components) and the myocardial perfusion imaging (CPT 78451-78454 range). Billing only the perfusion codes and missing the stress test component, or vice versa, is a common and correctable revenue gap.

Key CPT Codes for Nuclear Medicine Billing

  • CPT 78452: Myocardial perfusion imaging, tomographic, multiple studies at rest and stress. The most frequently performed nuclear cardiology study. Requires documentation of the clinical indication, the radiopharmaceutical administered, and the interpreted results. Medicare reimbursement is tied to the 2024 MPFS allowable, which has seen downward adjustments in recent years.
  • CPT 78816: Positron emission tomography (PET), whole body. Used for oncologic staging and restaging across multiple cancer types. Coverage is indication-specific under Medicare’s Coverage with Evidence Development framework for some tumor types. Verify coverage before scheduling.
  • CPT 78300: Bone imaging, whole body. Used for evaluation of metastatic disease, Paget disease, and stress fractures. Covered by Medicare and most commercial payers when supported by appropriate ICD-10 diagnosis coding (C-series for malignancy, M-series for metabolic bone disease).
  • CPT 78803: Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent, whole body. SPECT imaging code used for a range of diagnostic indications. Requires documentation of the clinical question being answered and the specific radiopharmaceutical agent.
  • CPT 93015: Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise. The stress test component of nuclear cardiology studies. When billed globally, includes supervision, interpretation, and report. When split, CPT 93017 covers supervision only and 93018 covers interpretation only.

Revenue Cycle Considerations for Nuclear Medicine

Nuclear medicine claims carry some of the highest per-claim values in outpatient diagnostic imaging, which means that every denial represents significant lost revenue. A/R days for nuclear medicine practices average 50 to 70 days, driven by payer review timelines for high-cost studies and prior authorization requirements at commercial payers. Medicare processes most nuclear medicine claims within standard timelines, but Medicaid programs and managed care organizations vary considerably in their review and payment cycles.

Your payer mix for nuclear medicine is often weighted more heavily toward Medicare and Medicare Advantage than general outpatient specialties, given the age and clinical complexity of the typical nuclear medicine patient. Medicare Advantage plans from Humana, UnitedHealthcare, and BCBS may apply more restrictive prior authorization requirements than traditional Medicare fee-for-service. Tracking those plan-specific requirements per patient is an essential front-end function your billing team needs to own.

How My Medical Bill Solution Helps Nuclear Medicine Practices

The complexity of nuclear medicine billing, from radiopharmaceutical HCPCS coding to professional and technical component splits to PET scan prior authorization management, requires a billing team that knows this specialty deeply. At My Medical Bill Solution, we bring that specialized knowledge to every claim we manage for nuclear medicine practices. We track your radiopharmaceutical charges, manage your prior authorization pipeline, and make sure that every component of every study is billed completely and correctly.

You provide some of the most diagnostically important imaging in medicine. Let My Medical Bill Solution make sure your practice is fully compensated for every study. Contact us today to learn more.

Common Questions

Frequently Asked Questions About Nuclear Medicine billing

Answers to the questions practice owners and managers ask most often before switching billing partners.

Why is radiopharmaceutical supply coding so important in nuclear medicine billing?

Radiopharmaceutical agents represent a significant cost in nuclear medicine. Each study requires a specific HCPCS supply code (A9500-A9700) billed alongside the procedure code. Missing the supply code means the practice absorbs the full cost of the isotope with no reimbursement, which can range from $50 to over $5,000 per dose.

What PET/CT indications are covered by Medicare?

Medicare covers PET/CT for initial staging and subsequent treatment monitoring of most solid tumors, certain brain disorders, and cardiac viability assessment. Coverage for other indications may require Coverage with Evidence Development (CED) or is determined by the local Medicare Administrative Contractor.

How do you handle billing for cardiac nuclear stress tests?

Cardiac stress testing with myocardial perfusion imaging (78451-78454) requires coding of the stress protocol (exercise or pharmacologic), the imaging study itself, and the radiopharmaceutical used (Tc-99m sestamibi, Tl-201). We ensure all components are captured and properly sequenced.

What are common denial reasons for nuclear medicine claims?

Common denials include missing radiopharmaceutical supply codes, lack of prior authorization for PET/CT studies, medical necessity disputes for repeat studies, and incorrect component billing. Our proactive review process addresses these issues before claim submission.

Do you bill for therapeutic I-131 treatments?

Yes. We handle the complete billing for I-131 thyroid ablation and therapy, including the procedure code (79005 or 79101), radiopharmaceutical supply code, dosimetry services, and follow-up whole body scans. We ensure documentation of thyroid cancer staging, prior TSH levels, and treatment rationale.

How do new radiopharmaceuticals affect billing?

New FDA-approved radiopharmaceuticals (such as PSMA agents for prostate cancer PET and Lu-177 for neuroendocrine tumors) receive new or updated HCPCS codes. We monitor CMS coding updates and payer coverage decisions to implement new codes as soon as they become billable.

Comparison

How We Compare for Nuclear Medicine billing

The difference is operational discipline. We focus on clean submissions, fast follow-up, and transparency.

Criteria My Medical Bill Solution Typical Provider
Specialty-specific billing workflows Included Often generic
Dedicated account ownership Yes Shared queue
Denial root-cause reporting Weekly Ad hoc
Claim submission speed Within 24 hours Varies
Communication cadence Planned check-ins Reactive only

Start Billing Smarter for Nuclear Medicine billing

Get a revenue review and a clear action plan tailored to your practice, payers, and claim mix.